Full year same store sales growth of 1%Decreased inventory by $29.1 million or 8.5%; reduced net debt by 6.1%Provides full year 2026 outlook WEST JORDAN, Utah, March 31, 2026 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. (“Sportsman's Warehouse” or the “Company”) (Nasdaq: SPWH) today announced financial results for the thirteen and fifty-two weeks ended January 31, 2026. “We are pleased with our improved fourth quarter finish and full-year performance, which exceeded our revised guidance followin ...

Confidential and Proprietary Information of Restaurant Brands International Safe Harbor Statement This presentation contains confidential and proprietary information of RBI. You should not share the information in this pres entation with any third parties. This presentation contains certain forward -looking statements and information, which reflect management's current beliefs and expectations regardi ng future events and operating performance and speak only as of the date hereof. You should not rely upon f ...

Core Insights - J.Jill, Inc. reported a decrease in net sales for both the fourth quarter and the full fiscal year 2025, with a 3.1% decline in Q4 and a 2.3% decline for the year [2][3] - The company declared a quarterly dividend of $0.09 per share, reflecting a 12.5% increase from the previous dividend [1][9] - The company is focused on sustainable growth through customer acquisition strategies and operational enhancements [2] Financial Performance - Fourth Quarter - Net sales for Q4 2025 were $138.4 million, down from $142.8 million in Q4 2024, a decrease of 3.1% [2] - Total comparable sales decreased by 4.8% in Q4 2025 [2] - Direct to consumer net sales increased by 2.6%, representing 53.5% of total net sales [2] - Gross profit was $87.3 million with a gross margin of 63.1%, down from $94.8 million and 66.3% respectively in Q4 2024 [2] - Operating loss was $0.2 million compared to an operating income of $5.1 million in Q4 2024 [2] - Net loss for Q4 2025 was $3.5 million, compared to a net income of $2.2 million in Q4 2024 [3] Financial Performance - Full Year - For the fiscal year ended January 31, 2026, net sales were $596.5 million, down from $610.9 million in the previous year [3] - Gross profit for the year was $409.7 million with a gross margin of 68.7%, compared to $429.9 million and 70.4% respectively in the prior year [3] - Operating income decreased to $50.6 million from $75.7 million in the previous year [3] - Net income for the year was $27.9 million, down from $39.5 million in the prior year [3] Shareholder Returns and Repurchase Program - The company repurchased 266,891 shares for approximately $3.8 million in Q4 2025 and 637,743 shares for about $10.4 million for the full year [5] - As of January 31, 2026, there was approximately $14.1 million remaining under the authorized $25 million share repurchase program [6] Outlook - The company expects net sales to decline by 5% to 7% and comparable sales to decline by 7% to 9% compared to fiscal 2025 [14] - Gross margin is anticipated to decline by approximately 400 basis points, incorporating an estimated $5 million in incremental tariff costs [14] - Adjusted EBITDA is projected to be between $15 million and $17 million for the upcoming fiscal year [14]

Fourth Quarter and Full Year 2025 Earnings March 30, 2026 Disclaimer The material that follows is a presentation ("Presentation") of information about Innventure, Inc. and its subsidiaries (together referred to herein as "Innventure," the "Company," "us," "our," or "we") as of the date of this presentation. The Presentation does not purport to contain all information that may be required or desired by a party interested in investigating the Company, its business or prospects, and it shall not be deemed to b ...

Core Insights - 51Talk Online Education Group reported significant growth in both gross billings and net revenues for the year 2025, with gross billings reaching US$127.6 million, an increase of 83.4% from US$69.6 million in 2024, and net revenues of US$95.6 million, up 88.6% from US$50.7 million in 2024 [5][21]. Full Year 2025 Financial and Operating Highlights - Gross billings for 2025 were US$127.6 million, an 83.4% growth from US$69.6 million for 2024 [2]. - Net revenues for 2025 were US$95.6 million, an 88.6% increase from US$50.7 million for 2024 [21]. - The number of active students with attended lesson consumption was approximately 170,300 in 2025, representing a 79.3% increase from approximately 95,000 in 2024 [20]. - Operating cash inflow for 2025 was US$11.8 million [6]. Fourth Quarter 2025 Financial and Operating Highlights - Gross billings for the fourth quarter of 2025 were US$36.8 million, a 72.0% growth from US$21.4 million for the fourth quarter of 2024 [2]. - Net revenues for the fourth quarter of 2025 were US$30.6 million, an 88.6% increase from US$16.2 million for the same quarter last year [8]. - The number of active students with attended lesson consumption was approximately 126,700 in the fourth quarter of 2025, a 70.8% increase from approximately 74,200 for the same quarter last year [8]. Cost and Operating Expenses - Cost of revenues for 2025 was US$24.9 million, representing a 123.4% increase from US$11.2 million for 2024 [21]. - Total operating expenses for 2025 were US$85.1 million, a 78.8% increase from US$47.6 million for 2024 [21]. - Sales and marketing expenses for 2025 were US$62.3 million, an 86.6% increase from US$33.4 million for 2024 [22]. Loss from Operations - Operating loss for 2025 was US$14.4 million, compared with an operating loss of US$8.0 million for 2024 [25]. - Net loss for 2025 was US$16.8 million, compared with a net loss of US$7.2 million for 2024 [25]. Outlook - For the first quarter of 2026, the company expects net gross billings to be between US$29.0 million and US$31.0 million, representing a sequential decrease of 15.7% to 21.2% but an increase of approximately 32.2% to 41.4% from the same quarter in 2025 [29].

Core Insights - Legence Corp. reported record quarterly revenues of $737.6 million for Q4 2025, marking a 34.6% increase from $548.2 million in Q4 2024, primarily driven by organic growth [1][4][3] - The company achieved a record total backlog and awarded contracts of $3.7 billion, a 49% increase year-over-year, with a robust book-to-bill ratio of 1.9x for Q4 [1][24][25] - Non-GAAP Adjusted EBITDA for Q4 2025 was $87.0 million, reflecting a 53.2% increase from $56.8 million in Q4 2024 [4][3] Financial Performance - Q4 2025 revenues totaled $737.6 million, up 34.6% from $548.2 million in Q4 2024 [4][5] - Gross profit for Q4 2025 was $147.5 million, with a gross margin of 20.0%, compared to $112.9 million and 20.6% in Q4 2024 [4][5] - For the full year 2025, total revenues reached $2.6 billion, a 21.5% increase from $2.1 billion in 2024 [5][8] Segment Performance - The Engineering & Consulting segment generated $172.6 million in revenue for Q4 2025, a 10.0% increase from $156.9 million in Q4 2024, driven by demand for Program & Project Management services [9][12] - The Installation & Maintenance segment reported revenues of $565.1 million for Q4 2025, a 44.4% increase from $391.3 million in Q4 2024, primarily due to strong demand from data centers and life sciences clients [16][18] - For the full year 2025, the Installation & Maintenance segment revenues totaled $1.8 billion, up 21.9% from $1.5 billion in 2024 [22][23] Backlog and Contracts - Total backlog and awarded contracts reached $3.7 billion as of December 31, 2025, a 48.6% increase from $2.5 billion a year earlier [24][26] - The Engineering & Consulting segment backlog increased by 16.2% year-over-year, while the Installation & Maintenance segment backlog surged by 65.8% [24][25] Acquisitions - On March 1, 2026, Legence completed the acquisition of Metrix Engineers LLC for approximately $30 million, enhancing its engineering capabilities in the Pacific Northwest [27][28] - The company also acquired Bowers on January 2, 2026, for an upfront cash payment of $325 million, funded through a combination of cash and debt [29] Guidance - For Q1 2026, Legence expects revenues between $925 million and $950 million, with Non-GAAP Adjusted EBITDA projected at $90 million to $100 million [30][31] - The full-year 2026 guidance has been raised to revenues of $3.7 billion to $3.9 billion and Non-GAAP Adjusted EBITDA of $400 million to $430 million [34]

Core Viewpoint - Instil Bio, Inc. is focusing on strategic development through potential acquisitions and in-licensing opportunities to enhance long-term shareholder value and advance innovative therapies for serious diseases [3][8]. Financial Position - As of December 31, 2025, Instil had a total cash position of $76.3 million, which is expected to fund its current operating plan beyond 2027. This is a decrease from $115.1 million as of December 31, 2024 [4][14]. - The cash position includes $6.6 million in cash and cash equivalents, $0.2 million in restricted cash, and $69.5 million in marketable securities [4]. Operating Results - In-process research and development expenses were nil for the fourth quarter of 2025 and $10.0 million for the full year, consistent with the previous year [5]. - Research and development expenses increased to $3.5 million for the fourth quarter and $24.7 million for the full year 2025, compared to $1.1 million and $11.8 million for the same periods in 2024 [5]. - General and administrative expenses decreased to $6.1 million for the fourth quarter and $27.2 million for the full year 2025, down from $10.4 million and $44.2 million in 2024 [6]. - Restructuring and impairment charges were $16.6 million for the full year 2025, compared to $7.5 million in 2024 [7]. Net Loss - The net loss per share for the fourth quarter was $1.21 and $10.70 for the full year 2025, compared to $1.82 and $11.39 for the same periods in 2024 [8][9]. - Non-GAAP net loss per share was $0.97 for the fourth quarter and $6.91 for the full year 2025, compared to $1.08 and $7.59 in 2024 [9][16]. Strategic Focus - The company has discontinued clinical development of AXN-2510 and is focusing on external innovation and disciplined capital deployment to identify high-quality opportunities across several therapeutic areas [8][12].

Financial Performance - Revenue for Q4 2025 was $104.0 million, a decrease of $163.3 million or 61.1% compared to Q4 2024 revenue of $267.3 million [2][11] - Gross loss for Q4 2025 was $193.4 million, compared to a gross profit of $7.7 million in Q4 2024, resulting in a gross margin decrease from 2.9% to (186.0)% [2][12] - Net loss attributable to stockholders for Q4 2025 was $216.4 million, or $(4.00) per share, compared to a net loss of $4.2 million, or $(0.09) per share in Q4 2024 [2][10] - EBITDA for Q4 2025 was $(202.2) million, compared to $(2.7) million in Q4 2024 [2][27] - Full year 2025 revenue was $772.2 million, down 21.2% from $980.2 million in 2024 [2][18] - Full year gross loss was $155.3 million, compared to a gross loss of $63.0 million in 2024, with gross margin decreasing from (6.4)% to (20.1)% [2][19] - Net loss attributable to stockholders for the full year 2025 was $306.5 million, or $(5.67) per share, compared to a net loss of $105.4 million, or $(2.19) per share in 2024 [2][16] Backlog and Strategic Initiatives - The company reported a backlog of $2.03 billion as of December 31, 2025 [2][28] - A strategic plan has been launched focusing on capital restructuring, liquidity support, asset monetization, and core market focus [3][6] - The company secured approximately $116 million in funding from sureties to support ongoing projects, with repayment terms being negotiated [6][7] - Recent project awards include $118 million in contracts, with a significant focus on higher-margin opportunities [3][6] Legal and Financial Adjustments - Q4 and full year 2025 results were impacted by a $135.8 million unfavorable adjustment related to an adverse ruling involving the Washington State Convention Center project [4][5] - The adverse ruling led to a long-term liability of $89.1 million and a reduction in revenue of $6.4 million for the quarter and year ended December 31, 2025 [5][4] - The company recorded a $40.3 million non-cash charge to revenue due to derecognition of contract assets as a result of the adverse ruling [5][4]

FOURTH QUARTER 2025 AND FY2025 EARNINGS RESULTS March 26, 2026 Forward-Looking Statements This presentation contains statements that are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on management's current expectations and assumptions and are subject to risks and uncertainties. Such statements include, but are not limited to, statements about (i) ...

Core Insights - Vroom, Inc. reported significant improvements in its financial performance for the full year 2025, with an adjusted net loss reduction of 57% from $115 million in 2024 to $49 million in 2025, attributed to strategic investments and operational focus [5][9]. Financial Highlights - As of December 31, 2025, Vroom's tangible book value was $104.2 million, with total stockholders' equity at $116.6 million, excluding intangible assets of $12.4 million [3][9]. - The company had total available liquidity of $48.7 million, which included $10.4 million in cash and cash equivalents, $11.3 million from warehouse credit facilities, and $27.0 million from a delayed draw facility [4][9]. - For the fourth quarter of 2025, Vroom reported a net loss from continuing operations of $(11.5) million, compared to $(36.0) million for the same period in 2024 [9][10]. Revenue and Income Analysis - Interest income for the fourth quarter of 2025 was $43.9 million, down from $48.7 million in the same quarter of 2024, reflecting a decrease of 10.8% [11]. - Total noninterest income for the fourth quarter was $7.9 million, a slight decrease from $8.5 million in the previous year [10]. - The company experienced realized and unrealized losses, net of recoveries, of $23.5 million in the fourth quarter, compared to $32.0 million in the same quarter of 2024, indicating an improvement [12]. Expense Management - Total expenses for the fourth quarter of 2025 were $27.0 million, significantly reduced from $41.2 million in the same quarter of 2024, marking a decrease of 65.1% [10][12]. - Compensation and benefits expenses decreased by 15.9% to $16.8 million in the fourth quarter of 2025 compared to $20.6 million in the same period of 2024 [10][12]. Segment Performance - In the UACC segment, interest income for the fourth quarter of 2025 was $43.9 million, down 10.8% from $49.2 million in the fourth quarter of 2024 [11]. - The CarStory revenue for the fourth quarter of 2025 was $1.3 million, a decline of 53.0% from $2.8 million in the same quarter of 2024 [13].